All systems operational
For Researchers For Publishers Login Register
Home Authors Hany Abdel Rahman
HA

Hany Abdel Rahman

h-5 H-Index
42 Citations
8 Papers

Published Papers

8 indexed
1
Outcome of pediatric parameningeal rhabdomyosarcoma. The Children Cancer Hospital, Egypt, experience
Journal of the Egyptian National Cancer Institute Q1 2013 10.1016/j.jnci.2013.01.002
10 citations 381
2
Role of FDG-PET scan in the management of pediatric mature B cell non-Hodgkin’s lymphoma. CCHE experience
Journal of the Egyptian National Cancer Institute Q1 2016 10.1016/j.jnci.2016.03.003
9 citations 383
3
Role of FDG-PET scan in the management of pediatric mature B cell non-Hodgkin’s lymphoma. CCHE experience
Journal of the Egyptian National Cancer Institute Q1 2016 10.1016/j.jnci.2016.03.003
9 citations 384
4
Results of treatment of lymphoblastic lymphoma at the children cancer hospital Egypt – A single center experience
Journal of the Egyptian National Cancer Institute Q1 2016 10.1016/j.jnci.2016.05.001
5 citations 383
5
Results of treatment of lymphoblastic lymphoma at the children cancer hospital Egypt – A single center experience
Journal of the Egyptian National Cancer Institute Q1 2016 10.1016/j.jnci.2016.05.001
5 citations 384
6
Did salvage ICE chemotherapy improve the outcome in primary resistant/relapsing stage III/IV neuroblastoma?
Journal of the Egyptian National Cancer Institute Q1 2011 10.1016/j.jnci.2011.07.007
4 citations 383
7
Corrigendum to “Outcome of pediatric parameningeal rhabdomyosarcoma. The Children Cancer Hospital, Egypt experience” [J Egypt Natl Cancer Instit 2013;25:79–86]
Journal of the Egyptian National Cancer Institute Q1 2016 10.1016/j.jnci.2016.01.001
0 citations 381
8
Corrigendum to “Outcome of pediatric parameningeal rhabdomyosarcoma. The Children Cancer Hospital, Egypt experience” [J Egypt Natl Cancer Instit 2013;25:79–86]
Journal of the Egyptian National Cancer Institute Q1 2016 10.1016/j.jnci.2016.01.001
0 citations 383

Publication Activity

Journals Published In

Journal of the Egyptian National Cancer Institute
🇪🇬 Q1 AMS 94